Cellular and biochemical actions of melatonin which protect against free radicals: Role in neurodegenerative disorders

Current Neuropharmacology

Volumn 6, Issue 3, 2008, Pages 203-214

  Ortiz, Genaro G ^a   Benítez King, Gloria A ^b   Rosales Corral, Sergio A ^a   Pacheco Moisés, Fermín P ^c   Velázquez Brizuela, Irma E ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Alzheimer; Melatonin; Neurodegeneration; NO; Oxidative stress; Parkinson

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BISINDOLYLMALEIMIDE; CALMODULIN INHIBITOR; DEFEROXAMINE; FREE RADICAL; GINKGO BILOBA EXTRACT; HYDROXYL RADICAL; LITHIUM; MELATONIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OKADAIC ACID; OPHIOBOLIN; OXYGEN; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCAVENGER; SELEGILINE; SUPEROXIDE; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIFFUSION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; HUMAN; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SCAVENGING SYSTEM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 53249154949     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015908785777201     Document Type: Review

References (140)

1. Acuña-Castroviejo, D., Coto-Montes, A., Gaia, M., Ortiz, G.G., Reiter, R.J. (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci., 60, 23-9.
2. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J.D. (1994) Molecular biology of the cell. Third Ed. Garland Publishers, Inc. N.Y.
3. Alvira, D., Tajes, M., Verdaguer, E., Acuña-Castroviejo, D., Folch, J., Camins, A., Pallas, M. (2006) Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease. J. Pineal Res., 40, 251-8.
4. Ames, B.N., Shigenaga, M.K., Hagen, T.M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA, 90, 7915-22.
5. Arnold, W.P., Mittal, C.K., Katsuki, S., Murad, F. (1985) Nitric oxide activates guanylate ciclase and increases guanosine 3′5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA, 74, 3203-7.
6. Bagetta, G., Corasaniti, M.T., Melino, G., Paoletti, A.M., Finazzi-Agro, A., Nistico, G. (1993) Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem. Biophys. Res. Commun., 197, 1132-39.
7. Becjman J.S., Koppenol, W.H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am. J. Physiol., 271, C1424-C1437.
8. Bekker, A., Holland, H.D., Wang, P.L., Rumble, D., Stein, H.J., Hannah, J.L., Coetzee, L.L., Beukes, N.J. (2004) Dating the rise of atmospheric oxygen. Nature, 427, 117-20.
9. Benitez-King, G, (2000) PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells. J. Pineal Res., 29, 8-14.
10. Benítez-King, G., Ortiz-López, L., Jiménez-Rubio, G. (2005) Melatonin precludes cytoskeletal collapse caused by hydrogen peroxide: Participation of protein kinase C. Therapy, 2, 767-78.
11. Benitez-King, G., Ramirez-Rodriguez, G., Ortiz, L. (2004) The neuronal cytoskeleton as a potential therapeutical target in neurodegenerrative diseases and schizophrenia 1. Curr. Drug Targets C.N.S. Neurol Disord., 3, 515-33.
12. Benitez-King, G., Rios, A., Martinez, A., Anton-tay, F. (1996) Ih vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin. Biochim. Biophys. Acta, 1290, 191-96.
13. Bicker, G. (2005) STOP and GO with NO: nitric oxide as a regulator of cell motility in simple brains. Bioessays, 27, 495-505.
14. Bredt, D.S., Snyder, S.H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requering enzyme. Proc. Natl. Acad. Sci. USA, 87, 682-5.
15. Brigelius-Flohe, R., Traber, M.G. (1999) Vitamin E: function and metabolism. FASEB J., 13, 1145-55.
16. Brocks, J.J., Logan, G.A., Buick, R., Summons, R.E. (1999) Archean Molecular Fossils and the Early Rise of Eukaryotes. Science, 285, 1033-6.
17. Brown, D. R. (2005) Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol., 43, 229-43.
18. Brown, G.C. (1997) Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischemic pathologies. Mol. Cell Biochem., 174, 189-92.
19. Brown, G. C. (2001) Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta, 1504, 46-57.
20. Brown, G.C., Cooper, C.E. (1994) Narromolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett., 356, 295-98.
21. Bus, J.S., Gibson, J.E. (1979) Lipid peroxidation and its role in toxicology. In: Hodgson, E., Bend, J., Philpo, R. Reviews in Biochemical Pharmacology. Elsevier/North Holland. Amsterdam, 1, 125-49.
22. Bush, A.I. (2900) Metals and neuroscience. Curr. Opin. Chem. Biol., 4, 184-91.
23. 2+, nitroxide spin probes, and synaptosomal membrane proteins. Life Sci., 58, 217-28.
24. Calzal, L., Giardino, L., Ceccatelli, S. (1993) NOS mRNA in the periventricular nucleus of young and old rats after immobilization stress. Neuroreport, 4, 627-30.
25. Carr, A., McCall, M.R., Frei, B. (2000) Oxidation of LDL by myeloperoxidase and reactive nitrogen species-reaction pathways and antioxidant protection. Arterioscl. Thromb. Vasc. Biol., 20, 1716-23.
26. Cassina, A., Radi, R. (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys., 328, 309-16.
27. Cecatelli, S., Hutling, A.L., Zhang, X., Gustafsson, L., Villar, M. (1993) Nitric Oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc. Natl. Acad. Sci. USA, 90, 11292-6.
28. Choi, J.H., Yu, B.P. (1995) Brain synaptasomal aging: Free radicals and membrane fluidity. Free Radic. Biol. Med., 18, 133-9.
29. Cifone, M.G., Cironi, L., Meccia, A., Roncaioli, P., Festuccia, C., De Nuntiis, G., D'A16, S., Santoni, A. (1995) Role of nitric oxide in cell-mediated cytotoxicity. Adv. Neuroimmunol., 5, 443-61.
30. Cleeter, M.W., Cooper, J.M., Darley-Usmar, V.M., Moncada, S., Schapira, A.H. (1994) Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett., 345, 50-4.
31. Cooper, C.E. (2002) Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector? Trends Biochem. Sci., 27, 33-39.
32. Double, K.L., Maywald, M., Schmittel, M., Riederer, P., Gerlach, M. (1998) In vitro studies of ferritin iron release and neurotoxicity. J. Neurochem., 70, 2492-9.
33. Elfering, S.L., Sarkela, T.M., Giulivi, C. Biochemistry of mitochondrial nitric-oxide synthase. (2002) J. Biol. Chem., 277, 38079-86.
34. Fang, F.C. (1997) Mechanisms of nitric-oxide-related antimicrobial activity. J. Clin. Invest., 100, S43-S50.
35. Farooqui, A.A., Horrocks, L.A. (1998) Lipid peroxides in the free radical pathophysiology of brain diseases. Cell. Mol. Neurobiol., 18, 599-608.
36. Fukutu, J.M., Chaudhwi, G. (1995) Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Ann. Rev. Pharm. Toxicol., 35, 165-94.
37. Garcia, J.J., Reiter, R.J., Guerrero, J.M., Escames, G., Yu, B.P., Ho, C.S., Muñoz-Hoyos, A. (1997) Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett., 408, 297-300.
38. Garthwaite, J., Boulton, C.L. (1995) Nitric oxide signaling in the central nervous system. Ann. Rev. Physiol., 57, 683-706.
39. Garthwaite, J., Boulton, C.L., Chess-Williams, R. (1998) Endothelium-derived relaxing factor release on activation of NMDA receptors suggest role as intercellular messenger in the brain. Nature, 336, 385-88.
40. Gaston, B., Drazen, J.M., Loscalzo, J., Stamler, J.S. (1994) The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med., 149, 538-51.
41. Gerschman, R., Gilbert, D.L., Nye, S.W., Dwyer, P., Fenn, W.O. (1954). Oxygen poisoning and x-irradiation: a mechanism in common. Science, 119, 623-26.
42. Ghost, C., Dick, R.M., Ali, S.F. (1993) Iron/ascorbate-induced lipid peroxidation changes membrane fluidity and muscarinic cholinergic receptor binding in rat frontal cortex. Neurochem. Int., 23, 479-84.
43. Griffith, O.W., Stuchr, D.J. (1995) Nitric oxide synthases: properties and catalytic mechanism. Ann. Rev. Physiol., 57, 707-36.
44. Guerrero, J.M., Reiter, R.J., Ortiz, G.G. Pablo, M, I., Sewerynek, E., Chuang, J.I. (1997) Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J. Pineal Res., 23, 4-31.
45. Gutteridge, J.M. (1994) Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann. N.Y. Acad. Sci., 738, 201-13.
46. Hamai, D., Bondy, S.C., Becaria. A., Campbell, A. (2001) The chemistry of transition metals in relation to their potential role in neurodegenerative processes. Curr. Top. Med. Chem., 1, 541-51.
47. Hardeland, R., Backhaus, C., Fadavi, A. (2007) Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J. Pineal Res., 43, 382-8.
48. Harman, D. (1956) Aging: a theory based on free radicals and radiation chemistry. J. Gerontol., 11, 298-300.
49. Hannan, D. (1994) Aging prospects of further increases in the functional life span. Aging, 17, 119-46.
50. Hauschildt, S., Scheipers, P., Bessler, W.G. (1992) Inhibitors of poly(ADPribose)-polymerase, suppress lipopolysaccharide-induced nitrite formation in macrophages. Biochem. Biophys. Res. Commun., 179, 865-71.
51. Hibbs, J.B., Vavrin, Z., Traintor, R.R. (1987) Larginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol., 138, 550-65.
52. Hibbs, J.B., Taintor, R.R., Vavrin, Z. (1987) Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science, 235, 473-6.
53. Honda, K., Casadesus, G, Petersen, R.B., Perry, G., Smith, M.A. 2004) Oxidative stress and redox-active iron in Alzheimer's disease. Ann. N. Y. Acad. Sci., 1012, 179-82.
54. Hsu, M., Srinivas, B., Kumar, J. Subramanian, R., Andersen, J. (2005) Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. J. Neurochem., 92, 1091-1103.
55. Huerto-Delgadillo, L., Anton-Tay, F., Benitez-King, G. (1994) Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J. Pineal. Res., 17, 55-62.
56. Knoll, A.H. (2003) The geological consequences of evolution. Geobiology, 1, 3-14
57. Kontos, H.A. (1985) George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circ. Res., 57, 508-16.
58. Koppal, T., Drake, J., Yatin, S., Jordan, B., Varadarajan, S., Bettenhausen, L., Butterfield, D.A. (1999) Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem., 72, 310-7.
59. Lan, J., Jiang, D.H. (1997) Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinsons disease. J. Neural Transm., 104, 649-60.
60. Lehninger, A.L., Nelson, D.L., Cox, M.M. (1993) Principles of Biochemistry. 2nd Ed. Worth publishers, New York NY.
61. Lenaz, G. (1998) Role of mitochondria in oxidative stress and ageing. Biochim. Biophys. Acta, 1366, 53-6.
62. Letechipia-Vallejo, G., López-Loeza, E., Espinoza-González, V., González-Burgos, L, Olvera-Cortés, ME., Moralf, G., Cervantes, M. (2007) Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats. J. Pineal Res., 42, 138-46.
63. Lin, M.T., Beal, M. F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443, 787-95.
64. Liu, V.W., Zhang, C., Nagley, P. (1998) Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. Nucleic Acids Res., 26, 1268-75.
65. Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., Markesbery, W.R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci., 158, 47-52.
66. MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fltecher, D.S., Trumbauer, M., Stevens, K., Xie, Q.W., Sokol, K., Hutchinson, N., Chen, H., Mudgett, J.S. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 81, 641.
67. MacMillan-Crow, L. A., Cruthirds, D. L., Ahki, K. M., Sanders, P. W., Thomson, J. A. (2001) Mitochondrial tyrosine nitration precedes chronic allograft nephropathy. Free Radic. Biol. Med., 31, 1603-8.
68. Maldonado, M.D., Murillo-Cabezas, F., Terron, M.P., Flores, L.J., Tan, D.X., Manchester, L.C., Reiter, R.J. (2007) The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J. Pineal Res., 42, 1-11.
69. Manda, K., Ueno, M., Anzai, K. (2007) AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res., 42, 386-93.
70. Matthews, R.T., Yang, L., Jenkins, B.G., Ferrante, R.J., Rosen, B.R., Kaddurah-Daouk, R., Beal, M.F. (1998) Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci., 18, 156-63.
71. Melchiorri, D., Sewerynek, E., Reiter, R.J., Ortiz, G.G., Poeggeler, P., Nistico, G. (1997) Suppressive effect of melatonin administration on ethanol-induced gastroduodenal injury in rats in vivo. Br. J. Pharmacol., 121, 264-70.
72. Melov, S., Schneider, J.A., Day, B.J., Hinerfeld, D., Coskun, P., Mirra, S.S., Crapo, J.D., Wallace, D.C. (1998) A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet., 18, 159-63.
73. Mielke, R., Moller, H.J., Erkinjuntti, T., Rosenkranz, B., Rother, M., Kittner, B. (1998) Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer Dis. Assoc. Disord., 12(Suppl 2), S29-35.
74. Mollace, V., Nistico, G. (1995) Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. Adv. Neuroimmunol., 5, 421-30.
75. Moncada, S., Erusalimsky, J. D. (2002) Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Biol., 3, 214-220.
76. Moncada, S., Palmer, R.M.J., Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-42.
77. Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C.L., Beyreuther, K. (1997) Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol., 54, 533-9.
78. Mundy, W.R., Freudenrich, T., Kodavanti, P.R. (1997) Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. Mol. Chem. Neuropathol., 32, 41-57.
79. Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., Carruba, M.O. (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science, 299, 896-9.
80. Nosál'ová, V., Zeman, M., Cerná, S., Navarová, J., Zakálová, M. (2007) Protective effect of melatonin in acetic acid induced colitis in rats. J. Pineal Res., 42, 364-70.
81. Okada, D. (1992) Two pathways of cyclic GMP production through glutamate receptor-mediate nitric oxide synthesis. J. Neurochem., 59, 1203-10.
82. Ortiz, G.G., Reiter, R.J., Zúñiga, G., Melchiorri, D., Sewerynek, E., Pablos, M.I., Oh, C.S., García, J.J., Bitzer-Quintero, O.K. (2000) Genotoxicity of paraquat: micronuclei induced in bone marrow and peripheral blood are inhibited by melatonin. Mutat. Res., 464, 239-45.
83. Ortiz, G.G., Sánchez-Ruiz, M.Y., Tan, D.X., Reiter, R.J., Beas-Zárate, C. (2000) Melatonin, vitamin E, and estrogen reduce damage induced by kainic acid in the hippocampus: potassium stimulated GABA release. J. Pineal Res., 31, 62-67.
84. Pablos, M.I., Reiter, R.J., Chuang, J.I., Ortiz, G.G., Guerrero, J.M., Sewerinek, E., Agapito, M.T., Melchiorri, D., Lawrence, R., Deneke, S.M. (1997) Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen. J. Appl. Physiol., 83, 354-58.
85. Pappolla, M.A., Chyan, Y.J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J., Reiter, R.J. (2000) An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural Transm., 107, 203-31.
86. Pedchenko, T.V., LeVine, S.M. (1998) Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J. Neuroimmunol., 84, 188-197.
87. Pitchumoni, S.S., Doraiswamy, P.M. (1998) Current status of antioxidant therapy for Alzheimer's disease. J. Am. Geriatr. Soc., 46, 1566-72.
88. Poeggeler, B., Saarela, S., Reiter, R.J., Tan, D.X., Chen, L.I., Manchester, L.C., Barlow-Walden, L.R. (1994) Melatonin-a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann. N.Y. Acad. Sci., 738, 419-20.
89. Radi, R., Cassina, A., Hodara, R. (2002) Nitric oxide and peroxynitrite interactions with mitochondria. J. Biol. Chem., 383, 401-9.
90. Ramirez-Rodriguez, G., Meza, I., Hernandez, M.E., Castillo, A., Benitez-King, G. (2003) Melatonin induced cyclic modulation of vectorial water transport in kidney-derived MDCK cells. Kidney Int., 63, 1356-64.
91. 2+. Eur. J. Biochem., 189, 547-52.
92. Reiter, R.J. (1994) The neuroimmune melatonin: its role in antioxidant protection with special reference to the brain. In: Krieglstein, J., Oberpichler-Schwenk H. (Hrsg.) Pharmacology of Cerebral Ischemia, Medpharm Scientific Publishers, Stuttgart, 287-296.
93. Reiter, R.J. (1995) Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging Clin. Exp. Res., 7, 340-51.
94. Reiter, R.J. (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol., 56, 359-84.
95. Reiter, R.J. (1998) Melatonin, active oxygen species and neurological damage. Drug News Persp., 11, 291-96.
96. Reiter, R.J., Cabrera, J., Sainz, R.M., Mayo, J.C., Manchester, L.C., Tan, D.X. (1999) Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism. Ann. N.Y. Acad. Sci., 890, 471-85.
97. Reiter, R.J., Guerrero, J.M., Escames, G., Pappolla, M.A., Acuña-Castroviejo, D. (1997) Prophylactic actions of melatonin in oxidative neurotoxicity. Ann N.Y. Acad. Sci., 825, 70-8.
98. Reiter, R.J., Melchiorri, D., Sewerynek, E., Poeggler, B., Barlow-Walden, L., Chuang, J., Ortiz, G.G., Acuña-Castroviejo, D. (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res., 18, 1-11.
99. Reiter, R.J., Ortiz, G.G., Monti, M.G., Cameiro, R.C. (1997) Cellular and molecular actions of melatonin as an antioxidant. In: Therapeutic potential of Melatonin. Front Horm. Res. (Karger, B., Maestroni, G.J.M., Conti, A., Reiter, R.J. Eds.), 23, 81-8.
100. Reiter, R.J., Pablos, M.I., Agapito, T.T., Guerrero, J.M. (1996) Melatonin in the context of free radical theory of aging. Ann. N.Y. Acad. Sci., 786, 362-78.
101. Reiter, R.J., Tan, D.X., Kim, S.J., Manchester, L.C., Qi, W., Garcia, J.J., Cabrera, J., EI-Sokkary, G., Rouvier-Garay, V. (1999) Augmentation of indices of oxidative damage in fife-long melatonin-deficient rats. Mech. Ageing Dev., 110, 157-73.
102. Reiter, R.J., Tan, D.X., Pappolla, M.A. (2004) Melatonin relieves the neural oxidative burden that contributes to dementias. Ann. N.Y. Acad. Sci., 1035, 179-96.
103. Samantaray, S., Sribnick, E.A., Das, A., Knaryan, V.H., Matzelle, D.D., Yallapragada, A.V., Reiter, R.J., Ray, S.K., Banik, N.L. (2008) Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J. Pineal Res., 44, in press.
104. Saravanan, K.S., Sindhu, K.M., Mohanakumar, K.P. (2007) Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J. Pineal Res., 42, 247-53.
105. Sattler, R., Xiong, Z., Lu, W.Y., Hafner, M., MacDonald, J.F., Tymianski, M. (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science, 284, 1845-48.
106. Schaad, N.C., Vanecek. J., Schultz, P.E. (1994) Photoneural regulation of rat pineal nitric oxide synthase. J. Neurochem., 62, 2496-99.
107. Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P., Marsden, C.D. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem., 54, 823-27.
108. Schultz, J.B., Mattehws, R.T., Jenkins, B.G., Ferrante, R.J., Siwek, D., Henshaw, D.R., Cipollini, P.B., Mecocci, P., Kowal, N.W., Rosen, B.R., Beal, M.F. (1995) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci., 15, 8419-29.
109. Sewerynek, E., Ortiz, G.G., Reiter, R.J., Pablos, M.I., Melchiorri, D., Daniels, M.U. (1996) Lipopolysaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Mol. Cell Endocrinol., 117, 183-8.
110. Sewerynek, E., Reiter, R.J., Melchiorri, D., Ortiz, G.G., Lewinski, A. (1996) Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology, 43, 898-905.
111. Sharma, R., McMillan, C.R., Niles, L.P. (2007) Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. J. Pineal Res., 43, 245-54.
112. Shiva, S., Brookes, P. S., Patel, R. P., Anderson, P. G., Darley-Usmar, V. M. (2001) Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc. Natl. Acad. Sci. USA, 98, 7212-17.
113. Shiva, S., Crawford, J.H., Ramachandran, A., Ceaser, E.K., Hillson, T., Brookes, P.S., Patel, R.P., Darley-Usmar, V.M. (2004) Mechanisms of the interaction of nitroxyl with mitochondria. Biochem. J., 379, 359-66.
114. Shizukuda, Y., Tang, S., Yokota, R, Ware, J.A. (1999) Vascular endothelial growth factor-induced endothehal cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C delta activity. Circ. Res., 85, 247-56.
115. Slater, S.J., Kelli, M.B., Taddeo, F.J., Ho, C., Rubin, E., Stubbs, C.D. (1994) The modulation of protein kinase C activity by membrane lipid bilayer structure. J. Biol. Chem., 269, 4866-71.
116. Smith, M.A., Harris, P.L., Sayre, L.M., Perry, G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA, 94, 9866-68.
117. Smith, T.S., Bennett, J.P. (1997) MitDchondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialys is infusion of methylpyridinium or azide ions. Brain Res., 765, 183-8.
118. Stuehr, D.J. (1999) Mammalian nitric oxide synthases. Biochim. Biophys. Acta, 1411, 217-30.
119. Stuehr, D.J., Marletta, M.A. (1985) Mammalian nitrate biosynthesis: mouse macrophage produce nitrate and nitrite in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA, 82, 7738-42.
120. Summons, R.E., Jahnke, L.L., Hope, J.M., Logan, G.A. (1999) 2-Methylhopanoids as biomatkers for cyanobacterial oxygenic photosynthesis. Nature, 400, 554-7.
121. Sun, A.Y., Chen, Y.M. (1998) Oxidative stress and neurodegenerative disorders. J. Biomed. Sci., 5, 401-14.
122. Szabó, C. (1996) Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull., 41, 131-41.
123. Tan, D.X., Manchester, L.C., Terron, M.P., Flores, L.J., Reiter, R.J. (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res., 42, 28-42.
124. Valko, M., Morris, H., Cronin, M.T.D. (2005) Metals, toxicity and oxidative stress. Curr. Med. Chem., 12, 1161-08.
125. Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., Mazur, M. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 160, 1-40.
126. Vandenberghe, W. (2000) AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J. Neurosci., 20, 123-32.
127. Van Landeghem, G.F., Sikstrom, C., Beckman, L.E., Adolfsson, R., Beckman, L. (1998) Transferrin C2, metal binding and Alzheimer's disease. Neuroreport, 9, 177-79.
128. Vaughan, M. (1997) Oxidative modification of macromolecules. J. Biol. Chem., 272, 18513.
129. Verge, V.M.K., Xu, Z., Xu, J., Wiesenfeld-Hallin, Z., Hokfelt, T. (1992) Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc. Natl. Acad Sci. USA, 89, 11617-21.
130. Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., Xu, D., Muller, W., Moncada, S., Liew, F.Y. (1995) Altered immune response in mice lacking inducible nitric oxide synthase. Nature, 375, 408-11.
131. Wrona, M.Z., Dryhurst, G. (1998) Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. Chem. Res. Toxicol., 11, 639-50.
132. Xu, J., Sun, S., Wei, W., Fu, J., Qi, W., Manchester, L.C., Tan, D.X, Reiter, R.J. (2007) Melatonin reduces mortality and oxidatively mediated hepatic and renal damage due to diquat treatment. J. Pineal Res., 42, 166-71.
133. Xu, W., Liu, L., Charles, I.G., Moncada, S. (2004) Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum. stress response. Nat. Cell Biol., 6, 1129-34.
134. Yamazaki, M., Chiba, K., Mohri, T. (2005) Fundamental role of nitric oxide in neuritogenesis of PC12h cells. Br. J. Pharmacol., 146, 662-9.
135. Yun, H. Y., Dawson, V. L., Dawson, T. M. (1996) Neurobiology of nitric oxide. Crit. Rev. Neurobiol., 10, 291-316.
136. Zang, J., Snyder, S.H. (1995) Nitric oxide in the nervous system. Annu. Rev. Pharmacol., 35, 213-33.
137. Zhang, J., Dawson, V.L., Dawson, T.M., Snyder, S.A. (1994) Nitric oxide activation of poly(ADP-ribose) synthase in neurotoxicity. Science, 263, 687.
138. Zhang, L., Wei, W., Xu, J., Min, F., Wang, L., Wang, X., Cao, S., Tan, D.X., Qi, W., Reiter, R.J. (2006) Inhibitory effect of melatonin on diquat-induced lipid peroxidation in vivo as assessed by the measurement of F2-isoprostanes. J. Pineal Res., 40, 326-31.
139. Zubenko, G.S. (1986) Hippocampal membrane alteration in Alzheimer's disease. Brain Res., 385, 115-21.
140. Zubenko, G.S., Cohen, B.M., Reynolds, C.F., Boller, F., Malinakova, I., Keefe, N. (1987) Platelet membrane fluidity in Alzheimer's disease and major depression. Am. J. Psychiatry, 144, 860-8.